EUVIMEDEUVIMED entdecken
Open Access

A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa

Saadiah Goolam, Hemant Kana, Nicky Welsh, Linda Wainwright, Janet Poole, Ismail Mayet

Ocular Oncology and Pathology · 2018 · 4 (3) · 170-175

DOI: 10.1159/000481508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 04.11.2017. Verfasst von Saadiah Goolam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ophthalmology, Department of Neurosciences, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesbur…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This paper presents a 20-year review of retinoblastoma in Johannesburg, South Africa, aiming to better characterize the disease in this sub-Saharan setting.

Methods

The study represents a retrospective case series of retinoblastoma patients presenting to Charlotte Maxeke Johannesburg Academic Hospital and Chris Hani Baragwanath Academic Hospital between January 1, 1992, and December 31, 2011.

Results

The total number of cases identified was 282, with 245 meeting the study inclusion criteria. Retinoblastoma comprised 6.9% of the total pediatric oncology presentations; 65.3% were unilateral, 34.3% bilateral, and 0.4% trilateral. The overall male-to-female ratio was 1.08. The mean age at presentation overall was 32.6 months (median 28.0), in the unilateral group 39.4 months (median 33.0), and in the bilateral group 19.7 months (median 17.0). The mean delay to presentation overall was 7.0 months (median 4.0). The most frequent presenting symptoms were leukocoria (37.1%) and proptosis (34.7%). The distribution of disease stages at presentation (International Retinoblastoma Staging System) was 1.6% stage 0, 24.1% stage I, 27.8% stage II, 16.3% stage III, and 25.3% stage IV. 26.5% defaulted care. The 5-year Kaplan-Meier survival estimate was 57.7% overall.

Conclusion

This study shows that delayed presentation and refusal of therapy remains a significant barrier to effective treatment in this African setting.

Schlagwörter

Stichwörter der Autor:innen

MortalityOcular oncologyRetinoblastomaSouth Africa

Autor:innen und Institutionen

  • Division of Ophthalmology, Department of Neurosciences, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
  • Division of Ophthalmology, Department of Neurosciences, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
  • Division of Paediatric Haematology and Oncology, Department of Paediatrics, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.
  • Division of Paediatric Haematology and Oncology, Department of Paediatrics, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa.

Zitieren

APA

Goolam, S., Kana, H., Welsh, N., Wainwright, L., Poole, J., & Mayet, I. (2018). A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa. Ocular Oncology and Pathology, 4(3), 170-175. https://doi.org/10.1159/000481508

Vancouver

Goolam S, Kana H, Welsh N, Wainwright L, Poole J, Mayet I. A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa. Ocular Oncology and Pathology. 2018;4(3):170-175. doi:10.1159/000481508

BibTeX
@article{Goolam2018,
  author = {Goolam, Saadiah and Kana, Hemant and Welsh, Nicky and Wainwright, Linda and Poole, Janet and Mayet, Ismail},
  title = {A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa},
  journal = {Ocular Oncology and Pathology},
  year = {2018},
  volume = {4},
  number = {3},
  pages = {170--175},
  doi = {10.1159/000481508}
}
Kostenlos starten →